| View |
|
BRP-034-02
|
Biphasic Isophane Insulin (rDNA)
|
Choicesulin
|
100 IU/mL
|
Suspension for Injection (SC)
|
Prescription Drug (Rx)
|
10 mL Glass Vial with Rubber Stopper and Brown Flip-Off Seal Box of 10's
|
Intermediate Acting Insulin
|
Wockhardt Limited
|
India
|
N/A
|
Ambica International Corporation
|
Medchoice Endocrine Group Inc.
|
Renewal
|
05 August 2022
|
05 September 2027
|
| View |
|
BRP-035
|
Regular Insulin Human (Rdna Origin)
|
Wosulin-R
|
100 IU/mL
|
Suspension For Injection (Sc)
|
Prescription Drug (RX)
|
10mL glass vial with rubber stopper and yellow flip-off seal
|
Short acting insulin
|
Wockhardt Limited
|
India
|
|
Ambica International Corp.
|
GX International Inc.
|
Renewal
|
20 May 2022
|
06 September 2027
|
| View |
|
BRP-035-01
|
Regular Insulin Human (Rdna Origin)
|
Glysolin R
|
100 I.U./ mL
|
Solution For Injection (S.C.)
|
Prescription Drug (RX)
|
10 mL glass vial with rubber stopper and yellow flip-off seal
|
Short acting insulin
|
Wockhardt Ltd.
|
India
|
|
Ambica International Corporation
|
The Cathay Drug Co., Inc.
|
Automatic Renewal
|
18 July 2022
|
06 September 2027
|
| View |
|
BRP-036
|
Isophane Insulin Human (Rdna Origin)
|
Wosulin-N
|
100 IU/mL
|
Suspension For Injection (Sc)
|
Prescription Drug (RX)
|
10mL glass vial with rubber stopper and green flip-off seal
|
Intermediate acting insulin
|
Wochard Limited
|
India
|
|
Ambica International Corp.
|
GX International Inc.
|
Renewal
|
20 May 2022
|
06 September 2027
|
| View |
|
BRP-036-01
|
Isophane Insulin Human (Rdna Origin)
|
Glysolin N
|
100 I.U./ mL
|
Suspension For Injection (S.C.)
|
Prescription Drug (RX)
|
10 mL glass vial with rubber stopper and green flip-off seal
|
Intermediate acting insulin
|
Wockhardt Ltd.
|
India
|
|
Ambica International Corporation
|
The Cathay Drug Co., Inc.
|
Automatic Renewal
|
18 July 2022
|
06 September 2027
|
| View |
|
BRP-037
|
Insulin Glargine
|
Glaritus
|
100IU/mL
|
Solution for Injection (SC)
|
Prescription Drug (RX)
|
3mL USP Type I Clear glass catridge with pen delivery device (Box of 1's)
|
Long-acting Insulin
|
Wockhardt Ltd.
|
India
|
|
Ambica International Corp.
|
Ambica International Corp.
|
Renewal
|
28 January 2019
|
03 March 2029
|
| View |
|
BRP-037-01
|
Insulin Glargine
|
Glysolin G
|
100 IU/mL
|
Solution For Injection (Sc)
|
Prescription Drug (RX)
|
3mL USP Type I Clear glass catridge with pen delivery device (Box of 1's)
|
Long-acting Insulin
|
Wockhardt Ltd.
|
India
|
|
Ambica International Corporation
|
THE CATHAY YSS DISTRIBUTORS CO., INC
|
Renewal
|
16 November 2023
|
03 March 2029
|
| View |
|
BRP-037-03
|
Insulin Glargine
|
Glarsulin
|
100 IU/mL
|
Solution For Injection (Sc)
|
Prescription Drug (RX)
|
3mL USP Type I Clear glass catridge with pen delivery device (Box of 1's)
|
Long-acting Insulin
|
Wockhardt Ltd.
|
India
|
|
Ambica International Corporation
|
Detoxicare Philippines, Inc.
|
Renewal
|
22 November 2023
|
03 March 2029
|
| View |
|
BRP-038
|
Isophane Insulin Human, Recombinant DNA
|
Wosulin-N
|
100 I.U./mL
|
Suspension For Injection (Sc)
|
Prescription Drug (RX)
|
USP Type I Clear and Colorless Glass Cartridge x 3 mL
|
Intermediate-acting Insulin
|
Wockhardt Limited
|
India
|
|
Ambica International Corporation
|
GX International, Inc.
|
Renewal
|
10 January 2019
|
29 March 2029
|
| View |
|
BRP-038-01
|
Isophane Insulin Human, Recombinant DNA
|
Glysolin N
|
100IU/Ml
|
Suspension for Injection (SC)
|
Prescription Drug (RX)
|
USP Type I clear and colourless glass catridge x 3mL (Box of 1's)
|
Intermediate-acting Insulin
|
Wockhardt Ltd.
|
India
|
|
Ambica International Corp.
|
The Cathay YSS Distributors Co., Ltd.
|
Renewal
|
14 November 2023
|
29 March 2029
|
| View |
|
BRP-039
|
Heparin Sodium
|
Nuparin
|
5000 IU/mL
|
Solution For Injection
|
Prescription Drug (RX)
|
5ML USP TYPE I AMBER VIAL
|
Anticoagulant
|
Troikaa Pharmaceuticals Limited
|
India
|
|
Troikaa Pharmaceuticals Philippines, Inc.
|
Troikaa Pharmaceuticals Philippines, Inc.
|
Renewal
|
25 January 2022
|
02 January 2027
|
| View |
|
BRP-040-01
|
Enoxaparin Sodium
|
Rifoxane
|
6000 IU Anti-Factor Xa (equivalent to 60 mg)/0.6 mL
|
Solution for Injection (SC)
|
Prescription Drug (Rx)
|
0.6 mL in 1 mL pre-filled syringe (Box of 1 blister pack)
|
Antithrombotic Agents
|
Brawn Laboratories Ltd.
|
India
|
N/A
|
Ambica International Corporation.
|
Rifemedica Corporation
|
Renewal (Reconstruction)
|
06 August 2024
|
09 December 2025
|
| View |
|
BRP-041-01
|
Enoxaparin sodium
|
Noxadium 4000
|
4000 IU Anti-Factor Xa (equivalent to 40mg)/0.4 mL
|
Solution For Injection (SC)
|
Prescription Drug (RX)
|
0.4 mL in 1 mL Pre-filled Syringe (Box of 1 Blister Pack)
|
Anticoagulant
|
Brawn Laboratories Ltd.
|
India
|
|
Ambica International Corporation
|
Central West Medicale Inc.
|
Renewal
|
24 January 2025
|
09 December 2025
|
| View |
|
BRP-041-02
|
Enoxaparin sodium
|
Rifoxane
|
4000 IU Anti-Factor Xa (equivalent to 40mg)/0.4 mL
|
Solution For Injection (Sc)
|
Prescription Drug (RX)
|
0.4 mL in 1 mL Pre-filled Syringe (Box of 1 Blister Pack)
|
Anticoagulant
|
Brawn Laboratories Ltd.
|
India
|
|
Ambica International Corporation
|
Rifemedica Corporation
|
Renewal
|
24 January 2025
|
09 December 2025
|
| View |
|
BRP-044
|
Human Albumin
|
Seroalbumin
|
200 g/L (20% w/v)
|
Solution for IV Infusion
|
Prescription Drug (RX)
|
50 mL and 100 mL USP Type I Glass Vial with Bromobutyl Rubber Stopper and Flip-off Aluminum Seal (Box of 1's)
|
-
|
Virchow Biotech Pvt. Ltd.
|
India
|
GSK Lifesciences Pvt. Ltd.
|
I.E. Medica Inc.
|
I.E. Medica Inc.
|
-
|
21 April 2021
|
09 February 2026
|
| View |
|
BRP-049
|
Filgrastim
|
Religrast
|
300 mcg/0.5 mL
|
Solution for Injection (IV/SC)
|
Prescription Drug (RX)
|
0.5 mL Pre-Filled Type I Glass Syringe with Needle in a Box (Single-dose)
|
Colony Stimulating Factors
|
Reliance Life Sciences Pvt. Ltd.
|
India
|
|
Ambica International Corporation
|
Ambica International Corporation
|
Renewal
|
23 May 2022
|
28 September 2027
|
| View |
|
BRP-049-01
|
Filgrastim
|
Grastigen
|
300 mcg/0.5 mL
|
Solution For Injection (IV/SC)
|
Prescription Drug (RX)
|
0.5 mL Pre-Filled Type I Glass Syringe with Needle in a Box (Single-dose)
|
Colony Stimulating Factors
|
Reliance Life Sciences Pvt. Ltd. (Plant II)
|
India
|
|
Ambica International Corp.
|
Genace Pharma Distributor
|
Automatic Renewal
|
08 July 2022
|
28 September 2027
|
| View |
|
BRP-049-02
|
Filgrastim
|
Timgrastix
|
300mcg/0.5mL
|
Solution For Injection (Iv/Sc)
|
Prescription Drug (RX)
|
0.5 mLpre-filled Type I glass syringe with needle a box (Single-dose)
|
Hematopoietic Growth Factor
|
Reliance Life Scienve Pvt. Ltd. (Pant II)
|
India
|
|
Ambica International Corporation
|
D&G Pharma
|
Automatic Renewal
|
08 July 2022
|
28 September 2027
|
| View |
|
BRP-050
|
Recombinant Alfa-2B
|
Reliferon
|
3 million IU/0.5 mL
|
Solution For Injection (Im/Sc)
|
Prescription Drug (RX)
|
Type I Glass Vial x 0.5mL (Box of 1's). Single dose
|
Antineoplastic and Immunomodulating Agents (Interferons)
|
Reliance Life Sciences Pvt. Ltd.
|
India
|
|
Ambica International Corporation
|
Ambica International Corporation
|
Automatic Renewal
|
12 September 2022
|
21 November 2028
|
| View |
|
BRP-052
|
Human Normal Immunoglobulin
|
Immunorel
|
5% (50 mg/mL)
|
Solution for Infusion IV
|
Prescription Drug (RX)
|
Glass Vial x 10 mL, 20 mL, 50 mL, 100 mL, and 200 mL (Box of 1's)
|
Immunoglobulin
|
Reliance Life Sciences Pvt. Ltd.
|
India
|
|
Ambica International Corp.
|
Ambica International Corp.
|
Renewal
|
24 May 2019
|
07 March 2029
|